Sarcopenia is defined as loss of skeletal muscle mass and function [34], and regarded to be associated with increased protein degradation and decreased protein synthesis in cancer patients with involvement of Akt-mTORC1 pathway in the presence of disturbed metabolic homeostasis, malnutrition, or reduced activity [35, 36]. The gene discussed is AKT1; the disease is sarcopenia.